Randomized trial details baseline participant characteristics in herpes zoster ophthalmicus, highlighting cohort features for evaluating long-term suppressive valacyclovir therapy.
The Zoster Eye Disease Study (ZEDS) is the first randomized clinical trial to study the efficacy of long-term (1 year) suppressive valacyclovir treatment on herpes zoster ophthalmicus (HZO) outcomes. This article details the baseline characteristics of participants.
No takes yet. Share an insight, caveat, or question.
Prescott et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: